Research Topics

Robert C Green

Summary

Affiliation: Boston University
Country: USA

Publications

  1. Green R, Roberts J, Cupples L, Relkin N, Whitehouse P, Brown T, et al. Disclosure of APOE genotype for risk of Alzheimer's disease. N Engl J Med. 2009;361:245-54 pubmed publisher
    ..Persons with high levels of emotional distress before undergoing genetic testing were more likely to have emotional difficulties after disclosure. (ClinicalTrials.gov number, NCT00571025.) ..
  2. Green R, Schneider L, Amato D, Beelen A, Wilcock G, Swabb E, et al. Effect of tarenflurbil on cognitive decline and activities of daily living in patients with mild Alzheimer disease: a randomized controlled trial. JAMA. 2009;302:2557-64 pubmed publisher
    ..Tarenflurbil did not slow cognitive decline or the loss of activities of daily living in patients with mild AD. clinicaltrials.gov Identifier: NCT00105547. ..

Detail Information

Publications2

  1. Green R, Roberts J, Cupples L, Relkin N, Whitehouse P, Brown T, et al. Disclosure of APOE genotype for risk of Alzheimer's disease. N Engl J Med. 2009;361:245-54 pubmed publisher
    ..Persons with high levels of emotional distress before undergoing genetic testing were more likely to have emotional difficulties after disclosure. (ClinicalTrials.gov number, NCT00571025.) ..
  2. Green R, Schneider L, Amato D, Beelen A, Wilcock G, Swabb E, et al. Effect of tarenflurbil on cognitive decline and activities of daily living in patients with mild Alzheimer disease: a randomized controlled trial. JAMA. 2009;302:2557-64 pubmed publisher
    ..Tarenflurbil did not slow cognitive decline or the loss of activities of daily living in patients with mild AD. clinicaltrials.gov Identifier: NCT00105547. ..